
Thyroid Cancer Red Flag: FDA Adverse Reporting Data Analysis Shows Alerts on Semaglutide, Tirzepatide Use
Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has raised important safety concerns regarding a potential link between thyroid cancer and several popular weight-loss medications. …